Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

MHRA: NSAID use should be as short as possible

Clinical NSAIDs should be used for the shortest time and at the lowest dose necessary, to minimise the risk of heart attack or stroke, the MHRA has reminded pharmacists.

NSAIDs should be used for the shortest time and at the lowest dose necessary, to minimise the risk of heart attack or stroke, the MHRA has reminded pharmacists.

The advice follows the publication of an international review that showed the use of popular NSAID, including diclofenac, can increase the risk of heart attack or stroke by a third.

Pharmacists should advise people to continue to take their NSAID medication as benefits outweighed the risks for most patients, the MHRA said.

The MHRA issued the safety warning on Wednesday, September 28, pointing out that the risks were already known.

The MHRA had evaluated all new evidence on the safety of NSAIDs as it had become available it said, and would continue to do so, it said.

For more information about NSAIDs and more, visit the

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD014590

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel